Related by context. Frequent words. (Click for all words.) 64 genetic polymorphisms 64 prognostic significance 63 KRAS mutations 63 multivariate analyzes 62 EGFR mutation 62 platelet reactivity 62 generalizability 62 molecular biomarkers 62 thrombophilia 62 EGFR mutations 61 liver transplant recipients 61 pharmacogenetic 61 sensitivity specificity 60 elevated CRP 60 atherothrombosis 60 lung fibrosis 60 estrogen receptor ER 60 fluvastatin 60 lymph node metastasis 60 risk stratification 60 potentially modifiable 60 subgroup analyzes 60 morbidity mortality 60 BRAF mutation 59 prognostic marker 59 mRCC 59 genetic determinants 59 metabolic parameters 59 HER2 positive metastatic breast 59 forodesine 59 prospectively defined 59 therapeutic regimens 59 Prognostic 59 serum vitamin D 59 tirofiban 59 virologic 59 pharmacodynamic effects 59 CYP#C# [001] 59 antigen PSA 59 HSCT 58 BRCA mutation 58 pharmacoeconomic 58 serologic 58 serum concentrations 58 genotypic 58 breast carcinoma 58 K RAS 58 biochemical recurrence 58 T2DM 58 genetic ancestry 58 pharmacokinetics PK 58 biodistribution 58 distant metastasis 58 prognostic factors 58 efficacy tolerability 58 comorbid conditions 57 HBsAg 57 prognostic factor 57 PCa 57 epithelial ovarian cancer 57 multiple myeloma MM 57 chronicity 57 optimal dosing 57 co morbidities 57 hsCRP 57 univariate 57 virologic response 57 aetiology 57 univariate analysis 57 lymph node metastases 57 POAG 57 biochemical markers 57 comorbidity 57 glucose homeostasis 57 morphologic 57 FDG PET 57 heavily pretreated 57 paclitaxel eluting stents 57 Azedra 57 surrogate markers 57 serum PSA 57 contralateral breast cancer 57 HERmark 57 fulvestrant 57 diagnostic biomarkers 57 sporadic ALS 57 IRESSA 56 thromboprophylaxis 56 enzastaurin 56 adjuvant radiation 56 CR# vcMMAE 56 EGFR inhibitors 56 predisposing factors 56 HCV genotype 56 haematological 56 antiplatelet therapy 56 HbA1C 56 Stat5 56 secondary efficacy endpoints 56 sustained virologic response 56 GFT#